FDA Proposes Registry On Thermal Ablation For Breast Cancer
This article was originally published in The Gray Sheet
Executive Summary
FDA says the development of a patient registry might help industry design better early-stage clinical trials for evaluating ablation as an alternative breast tumor treatment to more invasive surgery